MNLP – Module 5 – Self-assessment questions

Quiz-summary

0 of 5 questions completed

Questions:

You have already completed the quiz before. Hence you can not start it again.

Quiz is loading…

You must sign in or sign up to start the quiz.

You have to pass the previous Module’s quiz in order to start this quiz:

Results

Quiz complete. Results are being recorded.

Results

0 of 5 questions answered correctly

Congratulations on completing Self Assessment 5.

Proceed to Module 6 »

Proceed to Final Assessment 5 »

Return to the Module list »

Question 1 of 5

1. Question
Which of the following statements is not true?
- A. The aim of treatment is to prolong life, reduce symptoms and complications and maximise quality of life
- B. Treatment always starts as soon as a diagnosis of myeloma has been made
- C. Treatment for newly diagnosed patients can be divided into intensive and non-intensive pathways
- D. Patients with symptomatic myeloma have evidence of myeloma-related organ or tissue impairment
Correct

Incorrect
Question 2 of 5

2. Question
Which of the following suggest a patient is contraindicated to thalidomide?
- A. Are of child bearing age but unable to follow or comply with the required contraceptive measures
- B. Have thrombophilia
- C. Have other co-morbidities that potentially increase toxicity
- D. All of the above
Correct

Incorrect
Question 3 of 5

3. Question
The most common side-effect of Velcade is:
- A. Anaemia Insomnia
- B. Tingling, burning, numbness in the hands and feet
- C. Hearing loss or tinnitus
- D. Tremors
Correct

Incorrect
Question 4 of 5

4. Question
According to the International Myeloma Working Group (IMWG) uniform response criteria (2006), a very good partial response (VGPR) to therapy is defined as what percentage reduction in serum M protein?
- A. 50%
- B. 70%
- C. 80%
- D. 90%
- E. 95%
Correct

Incorrect
Question 5 of 5

5. Question
Which of the following statements is true?
- A. Maintenance treatment is treatment administered long term to maximise the depth of response obtained from the previous treatment
- B. Maintenance treatment is treatment administered long term with the aim of sustaining control of the myeloma
- C. Data from the Myeloma IX trial showed that patients with high risk or adverse cytogenetics benefitted from thalidomide maintenance treatment
- D. Velcade has been investigated more as a maintenance treatment than consolidation treatment
Correct

Incorrect

MNLP – Module 5 – Self-assessment questions

Quiz-summary

Information

Results

Results

Categories

1. Question

2. Question

3. Question

4. Question

5. Question